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affects donor T cell expansion, activation and migration. We com-
pared lethally irradiated vs. non-irradiated Balb/c (H-2d) mice that
received allogeneic luciferase FVB/N T cells (H-2q). In vivo
bioluminescence imaging (BLI) visualized the kinetics of aGVHD
and guided more detailed analyses. Irradiated wild type Balb/c,
Balb/c Rag/ and Balb/c Rag/cchain/ aHCT recipients
displayed comparable kinetics of aGVHD initiation in lymphoid
organs until day 3 and started intestinal inﬁltration by day 4,
skin and liver inﬁltration by day 5-6. All mice succumbed to
lethal aGVHD within two weeks after aHCT. Non-irradiated
Balb/c wild type recipients did not develop aGVHD. BLI revealed
the process of graft rejection after initial signal increase over lymphoid
organs by day3. In contrast donor cells overcame host resistance in
non-irradiated Balb/c Rag/ and Balb/c Rag/cchain/ mice.
However, despite proliferation in lymphoid organs, inﬁltration of
aGVHD target tissues was delayed. Balb/c Rag/ displayed moder-
ate and Balb/c Rag/cchain/ mice even weaker intestinal inﬁl-
tration on day 6. FACS analysis revealed that donor T cell subsets
were less activated in non-irradiated as compared to irradiated hosts.
Non-irradiated Balb/c Rag/cchain/ mice succumbed to lethal
aGVHDwithin twomonths after aHCT. Balb/c Rag/mice did not
die from aGVHD suggesting that host NK cells controlled alloreac-
tive T cells. In summary host conditioning exacerbates aGVHD by
increased alloreactive T cell activation and recruitment to aGVHD
target tissues.
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EPIDERMAL DENDRITIC CELL DEPLETION WITH MYELOABLATIVE
CONDITIONING THAT DOES NOT RECOVER POST TRANSPLANT
Hofmeister, C.C.1, Peterson, A.1, Tara, K.2, Stiff, P.1, Curry, J.1,
Nickoloff, B.J.1 1. Loyola Cardinal Bernardin Cancer Center, Maywood,
IL; 2. Lake Erie College of Osteopathic Medicine, Bradenton, FL.
Introduction: Cutaneous graft-versus-host disease (GVHD) is
an antigen presenting cell mediated process which leads donor T
lymphocytes to presumably target keratinocyte progenitor cells at
the dermal-epidermal junction. In the absence of inﬂammation,
epidermal dendritic cells (a.k.a. Langerhans cells or LCs) can
self-renew for long periods of time without the requirement for a
bone-marrow derived blood-borne precursor. Murine models have
suggested that depletion of host LCs pretransplant prevents cuta-
neous GVHD. We sought to determine epidermal dendritic cell
density pre-transplant, post-transplant, and with the onset of acute
GVHD. Methods: We reviewed all skin biopsies performed on
2101 stem cell transplants patients at Loyola University Medical
Center from 1995-2005. From these parafﬁn-embedded blocks, 20
randomly selected acute GVHD biopsies, all 17 biopsies of non-
GVHD rashes in post allograft patients, and 12 normal skin biop-
sies from reduction mammoplasties were obtained. In addition as
part of a prospective trial, 14 patients underwent punch biopsies
from December 2004 to August 2005 of grossly normal skin before
and immediately following the completion of their conditioning
regimens. All biopsies were stained for CD1a (LC marker) and the
number of suprabasal stained cells per high power ﬁeld (HPF) were
counted by a dermatopathologist. Results: Total body irradiation
containing (TBI) conditioning regimens nearly completely elimi-
nated epidermal LCs by the day of transplant. In comparison to
normal skin (44 CD1a cells  4.7 [95% CI]), acute GVHD
lesions showed a depletion of epidermal LCs (3.7 CD1a cells 
3.2 [95% CI]), but so did biopsies obtained post allograft without
GVHD (6.5 CD1a cells  3.6 [95% CI]). Conclusions: My-
eloablative conditioning regimens deplete epidermal LCs and this
reduction may remain post engraftment. UV dermatitis, topical
steroids or tacrolimus, viral infections (HPV, HIV), and GVHD all
induce LC depletion. The mechanism for this depletion is un-
known but mediators such as TNF-
 and IL-1 have induced LC
migration in murine models (Roake JE, J Exp Med, 1995). Our data
suggest that pretransplant LC depletion in humans will not prevent
cutaneous GVHD. Future studies will need to be performed to
determine the origin of LCs in post allograft patients.
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HOST LANGERHANS CELLS (LCs) CAN BE THERAPEUTICALLY MANIP-
ULATED IN VIVO WITH IMIQUIMOD (TLR7 AGONIST) TO AUGMENT
DLI-MEDIATED GVH AND GVL REACTIVITY
Skarica, M., Radojcic, V., Luznik, L. Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins, Baltimore, MD.
We recently found in murine models that after MHC-matched
allografting, the residual host LCs, the major dendritic cells (DCs)
of the skin, survive in epidermis despite the presence of large
numbers of peripheral donor T cells in the graft and conversion to
the full donor DC chimerism in blood. This observation led us to
hypothesize that in vivo manipulation of residual host LCs, which
persist in complete donor chimeras after MHC-matched allograft-
ing, may have a central role in augmenting DLI-mediated alloim-
mune responses. We tested our hypothesis in two murine models
of MHC-matched allografting. To manipulate T cell-LC interac-
tion in vivo we used the Toll-like receptor 7 (TLR7) ligand imi-
quimod. Topical application of imiquimod is known to augment in
situ maturation of the LCs and enhance their emigration from the
skin to the skin-draining lymph nodes (LNs). We ﬁrst tracked the
in vivo fate of DLI-derived T cells after their administration to the
8-week-old B6.SJL3C3H.SW complete donor chimeras that
were pretreated with vehicle or imiquimod. As DLI, we used
puriﬁed donor T cells from the B6.PL-Thy1a mice that differ in the
expression of Thy 1.1 allele. In the imiquimod treated group, the
expansion of DLI-derived Thy 1.1 T cells in LNs and spleen was
signiﬁcantly better than that of the vehicle-treated group. This
augmented DLI-mediated GVH response was also reﬂected by a
higher number of DLI-derived CD8 INF- secreting T cells and
by an increase in donor-derived LC chimerism in the imiquimod-
treated group. Next, we tested the effect of imiquimod on the GVL
reactivity of DLI. Four-week-old C3H.SW3C57/BL6 chimeras
constructed after lethal conditioning were pretreated with imi-
quimod prior to DLI administration and lethal challenge with
C1498 leukemia cells. Chimeras that received imiquimod and DLI
had superior leukemia-free survival in comparison to animals that
received DLI plus vehicle (P  .01) or imiquimod alone (P  .02).
The superior leukemia-free survival in the group that received DLI
plus imiquimod correlated also with faster conversion to full donor
CD8 T cell chimerism in comparison to the DLI plus vehicle
group (P  .01). In both models, we have not observed any
signiﬁcant clinical signs of GVHD. These results indicate that
imiquimod, through its action on LCs, can be used to enhance the
DLI-mediated alloimmune responses including their GVL reac-
tivity without exacerbating GVHD.
147
SIGNIFICANT DECREASE IN CORD BLOOD (CB) VERSUS ADULT PE-
RIPHERAL BLOOD (APB) MONOCYTE (MO)–DERIVED DENDRITIC CELL
(DC) GENE AND PROTEIN EXPRESSION PATTERNS AND T CELL FUNC-
TIONAL ACTIVATION: INSIGHT INTO IMMATURITY OF CB CELLULAR
IMMUNITY
Jiang, H.1, Wade-Harris, C.1, Baxi, L.2, Cairo, M.S.1,3,4 1. Depart-
ment of Pediatrics, Columbia University, New York, NY; 2. Department
of Obstetrics & Gynecology, Columbia University, New York, NY; 3.
Department of Medicine, Columbia University, New York, NY; 4.
Department of Pathology, Columbia University, New York, NY.
It has been recognized that dysfunction of CB cellular immunity
is in part due to the immaturity of the CB cellular immune system
(Cairo, 1997). However, biological pathways and molecular mech-
anisms associated with the immaturity of CB cellular immunity are
still poorly understood. Recently we have utilized oligonucleotide
microarray to examine gene expression proﬁle of CB vs APB Mo
and have demonstrated signiﬁcant differential gene expression pat-
terns (Jiang/Cairo, 2004). In the current study, differential ex-
pressed genes and proteins were examined in Mo-derived CB vs
APB DC by means of oligonucleotide microarray and proteomics.
Brieﬂy, Mo were puriﬁed and cultured for 8 days with GM-CSF,
IL-4 and LPS. Oligonucleotide microarray was carried out (Af-
fymetrix). The proteomic study was conducted by liquid chroma-
tography (LC) and tandem mass spectrometry (MS/MS). We iden-
tiﬁed gene expression patterns that were signiﬁcantly lower in CB
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